Critical function of Ikaros in controlling Aiolos gene expression

Area of Science:

• Immunology
• Molecular Biology
• Gene Regulation

Background:

• The Aiolos transcription factor plays a role in lymphoid development and function.
• Understanding the transcriptional regulation of Aiolos is essential for elucidating its biological roles.

Purpose of the Study:

• To characterize the promoter region of the lymphoid Aiolos transcription factor.
• To identify transcription factors that bind to and regulate the Aiolos promoter.

Main Methods:

• Cloning and functional analysis of the Aiolos promoter using nested deletions in lymphoid (Jurkat, U937) and non-lymphoid (HEK293) cell lines.
• Mapping of the transcription initiation site.
• Electrophoretic mobility shift assays (EMSA) to detect transcription factor binding.
• Site-directed mutagenesis of putative transcription factor binding sites.
• Chromatin immunoprecipitation (ChIP) assays to confirm in vivo binding.
• Overexpression studies of transcription factors and dominant-negative isoforms.

Main Results:

• Defined minimal promoter regions for Aiolos in different cell lines (172bp in Jurkat/HEK293, 370bp in U937).
• Identified Ikaros, NFkappaB, and AP4 as transcription factors binding to the Aiolos promoter.
• Demonstrated that mutations in these binding sites abolish promoter activity.
• Confirmed in vivo binding of Ikaros, NFkappaB, and AP4 to the Aiolos promoter via ChIP.
• Showed that overexpression of Ikaros and NFkappaB trans-activates the Aiolos promoter, driving expression in various cell types.
• Demonstrated that a dominant-negative Ikaros isoform inhibits Aiolos expression.

Conclusions:

• The Aiolos promoter is regulated by the transcription factors Ikaros, NFkappaB, and AP4.
• Ikaros and NFkappaB play critical roles in the trans-activation and expression of Aiolos in lymphoid cells.
• These findings provide insights into the molecular mechanisms controlling Aiolos expression during immune cell development and function.